Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Responsiveness of outcome measures in myotonic dystrophy type 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. No effect of triheptanoin on exercise performance in McArdle disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Early prediction of phenotypic severity in Citrullinemia Type 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Phenotypic Spectrum of α-Dystroglycanopathies Associated With the c.919T>a Variant in the FKRP Gene in Humans and Mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Vacuoles, Often Containing Glycogen, Are a Consistent Finding in Hypokalemic Periodic Paralysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Editorial: Remaining diagnostic issues and start of a treatment era for muscle diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Alexander P Murphy
  • Jasper Morrow
  • Julia R Dahlqvist
  • Tanya Stojkovic
  • Tracey A Willis
  • Christopher D J Sinclair
  • Stephen Wastling
  • Tarek Yousry
  • Michael S Hanna
  • Meredith K James
  • Anna Mayhew
  • Michelle Eagle
  • Laurence E Lee
  • Jean-Yves Hogrel
  • Pierre G Carlier
  • John S Thornton
  • John Vissing
  • Kieren G Hollingsworth
  • Volker Straub
View graph of relations

Objective: Limb girdle muscular dystrophy type R9 (LGMD R9) is an autosomal recessive muscle disease for which there is currently no causative treatment. The development of putative therapies requires sensitive outcome measures for clinical trials in this slowly progressing condition. This study extends functional assessments and MRI muscle fat fraction measurements in an LGMD R9 cohort across 6 years.

Methods: Twenty-three participants with LGMD R9, previously assessed over a 1-year period, were re-enrolled at 6 years. Standardized functional assessments were performed including: myometry, timed tests, and spirometry testing. Quantitative MRI was used to measure fat fraction in lower limb skeletal muscle groups.

Results: At 6 years, all 14 muscle groups assessed demonstrated significant increases in fat fraction, compared to eight groups in the 1-year follow-up study. In direct contrast to the 1-year follow-up, the 6-min walk test, 10-m walk or run, timed up and go, stair ascend, stair descend and chair rise demonstrated significant decline. Among the functional tests, only FVC significantly declined over both the 1- and 6-year studies.

Interpretation: These results further support fat fraction measurements as a primary outcome measure alongside functional assessments. The most appropriate individual muscles are the vastus lateralis, gracilis, sartorius, and gastrocnemii. Using composite groups of lower leg muscles, thigh muscles, or triceps surae, yielded high standardized response means (SRMs). Over 6 years, quantitative fat fraction assessment demonstrated higher SRM values than seen in functional tests suggesting greater responsiveness to disease progression.

Original languageEnglish
JournalAnnals of Clinical and Translational Neurology
Volume6
Issue number6
Pages (from-to)1033-1045
Number of pages13
ISSN2328-9503
DOIs
Publication statusPublished - Jun 2019

ID: 58148291